AU2003263585A1 - Amorphous duloxetine hydrochloride - Google Patents

Amorphous duloxetine hydrochloride

Info

Publication number
AU2003263585A1
AU2003263585A1 AU2003263585A AU2003263585A AU2003263585A1 AU 2003263585 A1 AU2003263585 A1 AU 2003263585A1 AU 2003263585 A AU2003263585 A AU 2003263585A AU 2003263585 A AU2003263585 A AU 2003263585A AU 2003263585 A1 AU2003263585 A1 AU 2003263585A1
Authority
AU
Australia
Prior art keywords
amorphous
duloxetine hydrochloride
duloxetine
hydrochloride
amorphous duloxetine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003263585A
Inventor
Dasari Muralidhara Reddy
Bandi Parthasaradhi Reddy
Rapolu Raji Reddy
Kura Rathnakar Reddy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hetero Drugs Ltd
Original Assignee
Hetero Drugs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Drugs Ltd filed Critical Hetero Drugs Ltd
Publication of AU2003263585A1 publication Critical patent/AU2003263585A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003263585A 2003-08-25 2003-08-25 Amorphous duloxetine hydrochloride Abandoned AU2003263585A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000280 WO2005019199A1 (en) 2003-08-25 2003-08-25 Amorphous duloxetine hydrochloride

Publications (1)

Publication Number Publication Date
AU2003263585A1 true AU2003263585A1 (en) 2005-03-10

Family

ID=34204121

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003263585A Abandoned AU2003263585A1 (en) 2003-08-25 2003-08-25 Amorphous duloxetine hydrochloride

Country Status (2)

Country Link
AU (1) AU2003263585A1 (en)
WO (1) WO2005019199A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1776049A2 (en) * 2005-01-27 2007-04-25 Teva Pharmaceutical Industries Ltd. Duloxetine hcl polymorphs
WO2006099433A1 (en) 2005-03-14 2006-09-21 Teva Pharmaceutical Industries Ltd. Pure duloxetine hydrochloride
US7759500B2 (en) 2005-12-05 2010-07-20 Teva Pharmaceutical Industries Ltd. 2-(N-methyl-propanamine)-3-(2-naphthol)thiophene, an impurity of duloxetine hydrochloride
EP1820800A1 (en) 2006-02-17 2007-08-22 KRKA, tovarna zdravil, d.d., Novo mesto Crystalline forms of duloxetine hydrochloride and processes for their preparation
GB0612506D0 (en) 2006-06-23 2006-08-02 Arrow Int Ltd Crystalline duloxetine hydrochloride
GB0612509D0 (en) 2006-06-23 2006-08-02 Arrow Int Ltd Crystalline duloxetine hydrochloride
EP2040697A2 (en) * 2006-07-03 2009-04-01 Ranbaxy Laboratories Limited Polymorphic form of duloxetine hydrochloride
EP2558455B1 (en) 2010-04-13 2017-08-09 KRKA, D.D., Novo Mesto Synthesis of duloxetine and/or pharmaceutically acceptable salts thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362886A (en) * 1993-10-12 1994-11-08 Eli Lilly And Company Asymmetric synthesis
WO2003062219A1 (en) * 2002-01-24 2003-07-31 Eli Lilly And Company Process for preparing an intermediate useful for the asymmetric synthesis of duloxetine

Also Published As

Publication number Publication date
WO2005019199A1 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
AU2003272930A1 (en) Footwere
AU2003902483A0 (en) A bioelastomer ii
AU2003263585A1 (en) Amorphous duloxetine hydrochloride
AU2003902474A0 (en) A bioelastomer i
AU2003902882A0 (en) Piperidyl derivatives
AU2003274573A1 (en) Deburrer
GB0314149D0 (en) Novel amorphous forms
AU2003278418A1 (en) Amorphous moxifloxacin hydrochloride
AU2003234859A1 (en) Description
AU2003304291A1 (en) A car-locking device
AU2003241210A1 (en) Videocomputer
AU2003211854A1 (en) Putter
AU2003100325A4 (en) Freez-A-Cube
AU2003100942A4 (en) Energenz
AU2003100378A4 (en) Scootermansydney
AU2003100198A4 (en) Colourband Browbands
AU2003100006A4 (en) Adcaster
AU152662S (en) A hinge
AU157678S (en) A hinge
AU157682S (en) A hinge
AU2003248104A1 (en) Crystalline 6-n-pyridylmethylaminoindolocarbazoles
AU2003905978A0 (en) A transfer line
AU2003902418A0 (en) Timing device
AU2003900380A0 (en) A device
AU2003905523A0 (en) A Backseal Device

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase